Visiox Pharma

Visiox is a biopharmaceutical company founded in 2019, headquartered in Tarrytown, New York, and led by CEO Ryan Bleeks. It focuses on the development and commercialization of ophthalmic therapeutic candidates to address highly prevalent diseases in need of new treatment options. The company’s leading products are PDP-716 and SDN-037.